HEARTBEAM INC (BEAT)       4.01  -0.15 (-3.61%)

HeartBeam Appoints Robert Eno as President

HeartBeam Granted European Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)

BEAM stock on watch on plans for telehealth solutions (NASDAQ:BEAT)

HeartBeam, Inc (BEAT) announced Thursday that it will start filing for its version 1 and version 2 HeartBeam AIMIGo telehealth solutions in early 2023. Read the full story here.

HeartBeam Issues Shareholder Letter and Provides Corporate Update

HeartBeam Partners with Evolve Manufacturing to Build HeartBeam AIMIGoTM 12-Lead 3D Vector Electrocardiogram Device

New HeartBeam Patent for 12-Lead Electrocardiogram (ECG) Smartwatch-based Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias

HeartBeam Reports Third Quarter 2022 Financial Results

HeartBeam to Host Third Quarter 2022 Results Conference Call on Thursday November 10, 2022 at 4:30 p.m. Eastern Time

GLSI, AVTE: The Top 5 Short Squeeze Stocks to Watch This Week

Short-squeeze stocks continue to be a big deal for speculative traders and we're helping them out with a list to keep in mind this week!

HeartBeam to Present at LD Micro Main Event XV Conference

HeartBeam Names Peter J. Fitzgerald, MD, PhD, as Chief Medical Officer

CapitalGainsReport: Sector Spotlight Medical Monitoring Stocks. (BEAT, DXCM, WHSI, NMRD, GBS)

Beat Of Life Entertainment- A One Stop Solution For Internet Marketing

Internet marketing is the solution for business development in the digitalization era.

Why Is HeartBeam (BEAT) Stock Up 24% Today?

HeartBeam (BEAT) stock is seeing gains on Thursday as investors react to news of it expanding its product portfolio pipeline.

HeartBeam Broadens Product Portfolio Pipeline with Smartwatch Connectivity Enablement for 24/7 Heart Monitoring Solution

HeartBeam to Present at Upcoming Investor Conferences

HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)